14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.20 $4.97 Thursday, 2nd May 2024 ALDX stock ended at $4.21. This is 0.238% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.57% from a day low at $4.09 to a day high of $4.24.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Mar 30, 2022 $4.97 $4.97 $4.51 $4.51 840 312
Mar 29, 2022 $5.23 $5.31 $4.83 $5.02 1 378 800
Mar 28, 2022 $4.88 $5.24 $4.86 $5.17 1 494 500
Mar 25, 2022 $4.79 $4.92 $4.72 $4.85 783 400
Mar 24, 2022 $4.80 $4.84 $4.57 $4.82 720 500
Mar 23, 2022 $4.95 $4.98 $4.74 $4.74 758 000
Mar 22, 2022 $4.85 $5.07 $4.81 $4.99 886 102
Mar 21, 2022 $5.10 $5.10 $4.76 $4.79 760 610
Mar 18, 2022 $4.79 $5.21 $4.79 $4.95 5 183 102
Mar 17, 2022 $4.37 $4.88 $4.16 $4.86 1 392 800
Mar 16, 2022 $3.90 $4.18 $3.82 $4.18 1 057 100
Mar 15, 2022 $3.83 $3.89 $3.75 $3.85 868 100
Mar 14, 2022 $4.09 $4.19 $3.66 $3.75 1 452 900
Mar 11, 2022 $4.27 $4.29 $4.10 $4.10 554 100
Mar 10, 2022 $4.26 $4.30 $4.07 $4.21 354 400
Mar 09, 2022 $4.17 $4.36 $4.08 $4.31 729 900
Mar 08, 2022 $3.77 $4.11 $3.68 $4.08 1 058 700
Mar 07, 2022 $3.48 $3.80 $3.44 $3.75 673 300
Mar 04, 2022 $3.65 $3.78 $3.48 $3.50 569 200
Mar 03, 2022 $3.98 $4.02 $3.66 $3.68 638 700
Mar 02, 2022 $3.95 $4.02 $3.87 $3.95 520 900
Mar 01, 2022 $4.05 $4.09 $3.86 $3.90 584 700
Feb 28, 2022 $4.04 $4.13 $3.87 $4.04 411 200
Feb 25, 2022 $4.09 $4.12 $3.87 $4.08 713 100
Feb 24, 2022 $3.55 $4.09 $3.53 $4.09 1 387 000
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT